Uditha deAlwis

Vice President, Analytical Development and Quality Control Sarepta Therapeutics

Seminars

Wednesday 2nd December 2026
Scientific Advisory Board Fireside Chat: Aligning on Future Analytical Standards to Reduce Risk & Improve Decision Making Across Cell & Gene Therapy
9:00 am

Meet the Scientific Advisory Board whose expertise has helped shape a highly relevant, industry focused agenda for this year’s meeting.

They will be exploring topics such as:

  • Defining priorities that shift analytical development from support function to core risk management
  • Identifying where challenges are similar and different across modalities and what that means for teams
  • Clarifying practical gaps that still limit progress across analytical development and QC
Wednesday 2nd December 2026
Improving AAV Product Quality by Looking Beyond Empty & Full Measurements
2:00 pm
  • Identifying how capsid integrity and DNA leakage provide additional quality insights
  • Understanding why empty and full measurements alone can miss critical product attributes
  • Evaluating how better formed viruses could reduce total viral load while maintaining activity
Uditha deAlwis